Cytori to Expand Scleroderma Focus to Broader Hand Therapy Franchise Under the Habeo™ Cell Therapy Brand
SAN DIEGO, Jan. 10, 2017 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (NASDAQ:CYTX), as part of its corporate update at the Biotech Showcase, announced its intention to broaden its investigation of the ECCS-50 formulation of Cytori Cell Therapy® to include secondary Raynaud’s phenomenon (RP) beyond scleroderma, a problem that affects over one million patients worldwide. Habeo... Read More →
TestEquity acquires JENSEN Tools + Supply
TestEquity acquires JENSEN Tools + Supply TestEquity acquires JENSEN Tools + Supply JENSEN Tools + Supply MOORPARK, Calif., Jan. 10, 2017 (GLOBE NEWSWIRE) — TestEquity, a one stop, value-added provider of premium electronic test & measurement equipment and MRO tools and supplies for 46 years, announced that it has acquired Massachusetts-based JENSEN Tools + Supply,... Read More →
Fiasp® (hurtigtvirkende insulin aspart) godkendt i Europa
PR170110_Fiasp_EMA_approval_DK.pdf Bagsværd, den 10. januar 2017 – Novo Nordisk meddeler i dag, at Europa-Kommissionen har givet markedsføringstilladelse til Fiasp® til behandling af diabetes hos voksne. Markedsføringstilladelsen gælder samtlige 28 EU-medlemslande. Fiasp® er varemærket for hurtigtvirkende insulin aspart. Fiasp® giver forbedret blodsukkerregulering, både generelt og i forbindelse med måltider, med en sammenlignelig sikkerhedsprofil i forhold til... Read More →
4 Things Gilead Sciences' CEO Says to Expect in 2017
Anyone expecting a surprise from Gilead Sciences ‘(NASDAQ: GILD) presentation at the 35th Annual J.P. Morgan Healthcare Conference on Monday would have walked away disappointed. John Milligan, Gilead’s CEO, stuck to his game plan for how the big biotech will move forward. Here are four things Milligan said to expect from Gilead Sciences in 2017.... Read More →
CAPMAN OYJ ON JULKISTANUT TEKEMÄNSÄ VAIHTOTARJOUKSEN JÄLKIKÄTEISEN TARJOUSAJAN ALUSTAVAN TULOKSEN
Helsinki, Suomi, 2017-01-10 14:30 CET (GLOBE NEWSWIRE) — Norvestia Oyj Pörssitiedote 10.1.2017 klo 15.30 Tätä pörssitiedotetta ei saa julkaista tai levittää, kokonaan tai osittain, suoraan tai välillisesti, henkilöille, jotka oleskelevat tai asuvat Yhdysvalloissa, Australiassa, Kanadassa, Hongkongissa, Japanissa, Uudessa-Seelannissa, Etelä-Afrikassa tai muutoin näissä maissa, tai missään muussa sellaisessa maassa, jossa sen julkaiseminen tai... Read More →
Company Announcement No 2 2016/17
The Supervisory Board of Investeringsselskabet Luxor A/S has today considered and adopted the Company’s Annual Report for 2015/16. Comments to the Annual Report: Basic earnings for the financial year increased from DKK 24.1 million in 2014/15 to DKK 31.1 million in 2015/16, which is in accordance with Company Announcement of 24 November 2016. The improvement... Read More →
Corvus Pharmaceuticals Announces Expansion of Renal Cell Carcinoma Cohort in Ongoing Phase 1/1b Clinical Study of Lead Checkpoint Inhibitor CPI-444
— Cohort Reached Protocol-Predefined Criteria for Expansion Based on Responses to Single-Agent Treatment — BURLINGAME, Calif., Jan. 10, 2017 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today announced that the protocol-predefined criteria for expansion has been reached for the cohort of patients... Read More →
Global Welding Products Market expected to reach USD 32.63 Billion by 2022: Zion Market Research
Sarasota, FL, Jan. 10, 2017 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Welding Products Market (SAW Wires and Fluxes, Solid Wires, Flux-cored Wires, Stick Electrodes,) Market for Building & Construction, Automobile & Transportation, Marine, Offshore and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”. According to... Read More →
CASMED Reports Preliminary Net Sales for the 2016 Fourth Quarter and Full Year
BRANFORD, Conn., Jan. 10, 2017 (GLOBE NEWSWIRE) — CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, reports preliminary unaudited top-line results for the three and 12 months ended December 31, 2016. The Company expects net sales from continuing operations for the fourth quarter of 2016 of approximately $5.5... Read More →
Coupa Acquires Spend360 to Modernize Processes for Data Analysis
SAN MATEO, Calif., Jan. 10, 2017 (GLOBE NEWSWIRE) — Coupa Software (NASDAQ:COUP), a leader in cloud-based spend management, today announced that it has acquired substantially all of the assets of Spend360 International Ltd. to help companies digitize antiquated processes for data classification. Based outside London, Spend360 is an analytics solution that uses deep machine learning... Read More →